Antiresorptive strategies in osteoporosis treatment.
Raisz
L G
LG
Division of Endocrinology and Metabolism, University of Connecticut Health Center, Framingham.
D000086:Acetazolamide / Q000627:therapeutic use; D000818:Animals; D001862:Bone Resorption / Q000503:physiopathology / Q000517:prevention & control*; D002116:Calcitonin / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D003012:Microbial Collagenase / Q000037:antagonists & inhibitors; D010010:Osteoclasts / Q000503:physiopathology; D010024:Osteoporosis / Q000188:drug therapy*; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D051381:Rats
D002257:Carbonic Anhydrase Inhibitors; D004164:Diphosphonates; D011448:Prostaglandin Antagonists; D002116:Calcitonin; D003012:Microbial Collagenase; D000086:Acetazolamide